from: Boshoff et al (2004). The transcriptional responses of Mycobacterium tuberculosis to inhibitors of metabolism. J Biol Chem.

Gene Expression Profile for Rv2236c/cobD

LFCtreatmentdescriptionclass of inhibitor

0.072

Amikacinug/mL Amikacintranslation

-0.144

Cap5-10ug/mL Capreomycintranslation

0.381

Rox10-50 ug/mL Roxithromycintranslation

-0.267

SM2-5 ug/mL Streptomycintranslation

-1.112

Tet5-10 ug/mL Tetracyclinetranslation

0.865

Rif0.2-5ug/mL Rifampicintranscription

-0.282

Rifp0.1-0.5ug/mL Rifapentinetranscription

1.879

Min_med__succinate_Minimal medium with succinate as sole carbon source as compared to growth in 7H9/ADC/Tween/glycerolstarvation

-0.397

CCCP10-50 uM Carbonyl cyanide 3-chlorophenylhydrazonerespiration

-0.005

CPZ10-50 ug/mL Chlorpromazinerespiration

-0.867

Clofazimine10-13 ug/mL Clofaziminerespiration

0.018

Clotrimazole10-24 ug/mL Clotrimazole (azole drug)respiration

-0.142

DCCD20-100 uM Dicyclohexylcarbodiimiderespiration

-1.029

DNP"0.5-2.5 mM 2,4-Dinitrophenol"respiration

0.622

DTT"1-2 mM 1,4-Dithio-DL-threitol"respiration

-0.312

Econazole10-24 ug/mL Econazole (azole drug)respiration

0.000

GSNO_CFZ0.1 mM S-Nitrosoglutathione + 5 ug/mL Clofaziminerespiration

1.000

GSNO_CPZ0.1 mM S-Nitrosoglutathione + 20-25 ug/mL Chlorpromazinerespiration

-0.159

GSNO_KCN0.1mM S-Nitrosoglutathione + 5ug/mL potassium cyaniderespiration

0.641

GSNO_menadione0.1 mM S-Nitrosoglutathione + 6-10 ug/mL menadionerespiration

-1.575

KCN5-20 ug/mL Potassium cyaniderespiration

0.316

NaN30.2-2 mM Sodium aziderespiration

-0.015

Nigericin50 uM Nigericinrespiration

0.105

TRC10-150 ug/mL Triclosanrespiration

-0.137

TRZ10-25 ug/mL Thioridazinerespiration

0.791

Valinomycin0.5-10 uM Valinomycinrespiration

0.000

ZnSO42 mM ZnSO4respiration

0.614

menadione6-10 ug/mL Menadionerespiration

0.433

Ascididemin_Nat_prod4-9 ug/mL Organic extract of Eudistoma amplumironLimitation

-0.231

Deferoxamine150-250 uM Deferoxamine mesylateironLimitation

0.355

Dipyridyl"100-200 uM 2,2'-Bipyridyl"ironLimitation

0.187

GSNO0.02-0.1mM S-NitrosoglutathionedosRassociated

1.768

NRP_1Non-replicating persistence stage 1dosRassociated

-0.685

Amp0.2mg/mL AmpicillincellWall

0.064

Cephalexin20-100 ug/mL CephalexincellWall

0.278

Cerulenin0.32-5 ug/mL CerulenincellWall

-1.015

DIPED5-100 ug/mL DiisopropylethylenediaminecellWall

-0.466

EMB10-20 ug/mL EthambutolcellWall

-0.216

Eta12-40 ug/mL EthionamidecellWall

-0.247

INH0.2-0.4 ug/mL IsoniazidcellWall

-0.278

TLM0.1-0.2 mg/mL ThiolactomycincellWall

0.271

PalmitateMinimal medium with palmitate as sole C-source as compared to minimal medium with glucose as sole CsourcecarbonSource

-0.356

SuccinateMinimal medium with succinate as sole C-source as compared to minimal medium with glucose as sole CsourcecarbonSource

0.326

BZA0.12 mg/mL BenzamidearomaticAmides

0.220

Nam0.12 - 1.2 mg/mL NicotinamidearomaticAmides

-0.090

PZA0.12-1.2 mg/mL PyrazinamidearomaticAmides

0.360

H2O24 mM hydrogen peroxideDNAdamaging

0.187

Levo10 ug/mL LevofloxacinDNAdamaging

-0.367

Mtm0.1-0.2 ug/mL Mitomycin CDNAdamaging

-0.384

Novobiocin10 ug/mL NovobiocinDNAdamaging

-0.534

Oflox5-10 ug/mL OfloxacinDNAdamaging

-1.020

UVUV-irradiationDNAdamaging

0.297

ARP41-4 ug/mL Antitubercular compound ARP4?

-0.077

Antimycin12.5-50 ug/mL Antimycin A?

0.506

DTNB"1-2 mM 5,5'-Dithiobis(2-nitrobenzoic acid)"?

0.452

PA_110-50 ug/mL Antitubercular compound PA-1?

0.389

PA_2110-50 ug/mL Antitubercular compound PA-21?

-0.889

PA8240.2-2 ug/mL PA-824?

0.312

Procept_677620-30 ug/mL Antitubercular compound Procept 6776?

0.665

Procept_67785-40 ug/mL Antitubercular compound Procept 6778?

-0.157

Verapamil50 uM Verapamil?

0.622

mercaptoethanol2 mM 2-Mercaptoethanol?

-0.784

methoxatin10-20 ug/mL Methoxatin?